USFDA, DCA hold second regulatory forum in Hyderabad
The Drugs Control Administration (DCA), Telangana, and the US Food and Drug Administration (USFDA) held their second regulatory forum in Hyderabad, focusing on knowledge-sharing, advanced GMP practices, and collaborative inspection approaches to strengthen public health standards.
Hyderabad: The second regulatory forum between representatives of Drugs Control Administration (DCA), Telangana and their counterparts from the United States Food and Drug Administration (USFDA) was held on Tuesday at DCA Headquarters in Vengalrao Nagar in the city.
The regulatory forum served as a knowledge-sharing platform aimed at exchanging and learning best regulatory practices related to the inspection of medical products and the advancement of public health. Several technical sessions on Advanced Good Manufacturing Practices (GMP) concepts were delivered by USFDA investigators during the forum, a statement from DCA said.
The DCA officers presented their recent initiatives, inspection approaches, and inspection trends, particularly with regard to Revised Schedule M and sterile manufacturing facility inspections.
The forum significantly enhanced the understanding of DCA inspectors regarding USFDA regulatory requirements and best practices, strengthening collaborative efforts in regulatory practices and public health, the release added.
The USFDA officials included Greg Smith, Country Director, Lisa Flores, Regulatory Specialist (Pharmaceuticals), Rafeeq Habeeb, Regulatory Specialist (Pharmaceuticals); and Dhruv Shah, Senior Technical Advisor.
